If you have specific concerns about thrombotic risk, discuss your individual risk profile with your GP or diabetes specialist, who can provide personalised advice and, if necessary, arrange appropriate investigations or referrals
While initially a concern, the rate of pancreatitis does not appear to be significantly increased by GLP-1RA based on a pooled analysis of 33,457 patients enrolled in cardiovascular outcome trials [184]
In particular, tell your provider if you have or had a past history of: Type 1 or type 2 diabetes Thyroid cancer Gastrointestinal disease Pancreatitis Kidney disease Diabetic retinopathy Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding
10.1016/j.cell.2015.11.055 163 WangZ.ShaoY.WuF.LuoD.HeG.LiangJ.et al (2024)
There is also a very practical issue with tirzepatide: delayed gastric emptying can reduce absorption of oral contraceptives, and UK guidance advises additional contraception around initiation and dose escalations
Lo que dice Marcela es correcto, aunado a eso quiero hacerte incapie en que el efecto de levocarnitina es variable segn los pacientes, la dosis, y la deficiencia que presenten
